Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - dasatinib - film-coated tablet - 50 milligram(s) - dasatinib

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - dasatinib - film-coated tablet - 70 milligram(s) - dasatinib

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dasatinib, quantity: 70 mg - tablet, film coated - excipient ingredients: triethyl citrate; hypromellose; colloidal anhydrous silica; hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; ethylcellulose; titanium dioxide - dasatinib arx is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dasatinib, quantity: 100 mg - tablet, film coated - excipient ingredients: triethyl citrate; lactose monohydrate; hypromellose; hyprolose; colloidal anhydrous silica; titanium dioxide; croscarmellose sodium; ethylcellulose; microcrystalline cellulose; magnesium stearate - dasatinib arx is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dasatinib, quantity: 20 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; triethyl citrate; lactose monohydrate; hyprolose; microcrystalline cellulose; colloidal anhydrous silica; hypromellose; titanium dioxide; magnesium stearate; ethylcellulose - dasatinib arx is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dasatinib, quantity: 50 mg - tablet, film coated - excipient ingredients: ethylcellulose; hyprolose; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; hypromellose; titanium dioxide; lactose monohydrate; magnesium stearate; triethyl citrate - dasatinib arx is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 20 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 50 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 70 mg - antineoplastic agents

Malta - English - Medicines Authority

synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 80 mg - antineoplastic agents